Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hardikkumar Jetani

1PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jul 21, 2021
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.

Hardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher

Pageof 1

Frequent Collaborators

1 joint publications

Almudena Navarro-Bailón

1 joint publications

Marius Maucher

1 joint publications

Silke Frenz

1 joint publications

Ana Yeguas

1 joint publications

María Belén Vidriales

1 joint publications

Marcos González

1 joint publications

Katrin Mestermann

1 joint publications

Halvard Bonig

1 joint publications

Michael Hudecek

Frequent Collaborators

1 joint publications

Almudena Navarro-Bailón

1 joint publications

Marius Maucher

1 joint publications

Silke Frenz

1 joint publications

Ana Yeguas

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

922
See more related videos

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

922
See more related videos